5J3.F SCIBASE HOLDING AB

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
0.0164 EUR
Close of Jun 6, 2026
0.0200 4.22
Market cap
EUR 168K
P/E
-
P/B
6.18x
ROE
-353.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 5J3.F undervalued?

Graham number

The Graham number of SCIBASE HOLDING AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SCIBASE HOLDING AB fundamental analysis

No fundamental analysis for SCIBASE HOLDING AB yet.

SCIBASE HOLDING AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SCIBASE HOLDING AB

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration w…

Full company profile